Latest Breaking News On - Vistagen therapeutics - Page 6 : vimarsana.com

VistaGen Therapeutics (VTGN) Appoints Joshua Prince as COO

VistaGen Therapeutics (VTGN) Appoints Joshua Prince as COO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTeva pharmaceuticalsUniversity of missouriPennsylvania state universityGlobal insightCompany senior viceJoshua princeChief operating officerVistagen therapeuticsSenior vice presidentBusiness operationsNorth american leadCommercial insightSenior directorMechanical engineeringPennsylvania state

PRISM MarketView Launches Mental Health Index on World Mental Health

PRISM MarketView Launches Mental Health Index on World Mental Health .

United statesCingulate incDepression association of americaPrism emerging mental health indexVistagen therapeutics incNational alliance on mental illnessWorld mental health dayNews networkSage therapeutics incTalkspace incView launches mental health indexWorld mental healthHighlights innovative companies addressingUnseen challengesMental disordersNational alliance

InvestorNewsBreaks — Vistagen Therapeutics Inc (NASDAQ: VTGN) Announces Participation in Inaugural Biotech CNS/Neuro Summit

InvestorNewsBreaks — Vistagen Therapeutics Inc (NASDAQ: VTGN) Announces Participation in Inaugural Biotech CNS/Neuro Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLos angelesTherapeutics incVistagen therapeuticsJefferies biotechDynamic brand portfolio

12 Health Care Stocks Moving In Thursday s After-Market Session - China Pharma Holding (AMEX:CPHI), Inhibikase Therapeutics (NASDAQ:IKT), SomaLogic (NASDAQ:SLGC), Bone Biologics (NASDAQ:BBLG)

Pharma holdingBiopharma coInhibikase therapeuticsFreeline therapeuticsVistagen therapeutics

Vistagen Announces Pricing of $100 Million Underwritten Offering

Vistagen Therapeutics, Inc. , a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous.

San franciscoUnited statesRiverside plazaNew yorkWilliam blairVistagen therapeutics incEquity syndicate prospectus departmentExchange commissionNicolaus company incorporatedProspectus departmentWilliam blair companyVistagen therapeuticsCommodore capitalGreat point partnersLogos capitalNantahala capital